Citadel Advisors LLC 13D and 13G filings for VYNE Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 5:28 pm Sale | 2025-03-31 | 13G | VYNE Therapeutics Inc. VYNE | Citadel Advisors LLC | 1,100,329 7.200% | -80,815 (-6.84%) | Filing |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | VYNE Therapeutics Inc. VYNE | Citadel Advisors LLC | 1,181,144 8.500% | -23 (-0.00%) | Filing |
| 2023-11-13 4:41 pm Purchase | 2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE | Citadel Advisors LLC | 1,181,167 8.500% | 1,181,167 (New Position) | Filing |